Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Gross Profit | 8,180 | 7,540 | 6,030 | 7,090 | 7,590 |
| Operating Expenses | 7,600 | 10,340 | 6,950 | 3,840 | 9,960 |
| Operating Income | -7,600 | -10,340 | -6,950 | -3,840 | -9,960 |
| Pre-tax Income | -7,600 | -10,340 | -6,950 | -3,840 | -9,960 |
| Net Income Continuous | -7,600 | -10,340 | -6,950 | -3,840 | -9,960 |
| Net Income | $-7,600 | $-10,340 | $-6,950 | $-3,840 | $-9,960 |
| EBITDA(a) | $-6,830 | $-9,160 | $-5,930 | $-2,790 | $-8,770 |